Breaking News Instant updates and real-time market news.

BIOYF

Biosyent

$6.49 /

+ (+0.00%)

08:24
05/18/22
05/18
08:24
05/18/22
08:24

Biosyent reports Q1 EPS C$0.13 vs. C$0.13 last year

Reports Q1 revenue C$7M vs. C$7.4M last year. "Our Canadian pharmaceutical business continued to grow during the first quarter in spite of the impacts on selling activities and patient volumes from the spread of the Omicron variant of COVID-19," commented Mr. Rene Goehrum, President and CEO of BioSyent. "While sales of our launch brand Combogesic were most acutely affected, our other continuing Canadian pharmaceutical brands, including launch brand Tibella, all showed sales growth during the first quarter. At the end of 2021, we discontinued the sale of two Canadian pharmaceutical brands. In the absence of these brands, our rebalanced portfolio of Canadian pharmaceutical brands grew by 8% during the quarter on a comparative basis. Although our international pharmaceutical business recorded export sales of FeraMAX of $0.6 million during the quarter, there was a large single FeraMAX export sale of $1.1 million in the comparative period, resulting in a decline in total Company sales of 5% on a comparative basis. With the growing contribution of Tibella and the discontinuation of unprofitable brands at the end of 2021, the Company's net profit margin increased to 23% in Q1 2022 as it marked its 47th consecutive profitable quarter, even as the Company made significant investments during the quarter in expanding its field salesforce across Canada. As access to healthcare professionals improves with more opportunities for in-person engagement, I look forward to reporting on our progress during 2022."

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Bank OZK downgraded to Market Perform from Outperform at Raymond James » 06:36
07/07/22
07/07
06:36
07/07/22
06:36
OZK

Bank OZK

$37.80 /

-0.595 (-1.55%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OZK Bank OZK
$37.80 /

-0.595 (-1.55%)

OZK Bank OZK
$37.80 /

-0.595 (-1.55%)

05:03 Today Wells Fargo
Bank OZK downgraded to Equal Weight from Overweight at Wells Fargo
06/15/22 Truist
Bank OZK price target lowered to $42 from $44 at Truist
04/27/22 Citi
Bank OZK price target lowered to $45 from $50 at Citi
04/25/22 Truist
Bank OZK price target lowered to $44 from $53 at Truist
OZK Bank OZK
$37.80 /

-0.595 (-1.55%)

OZK Bank OZK
$37.80 /

-0.595 (-1.55%)

Hot Stocks
Thor Industries' Vice President of Investor Relations Mark Trinske to retire » 06:36
07/07/22
07/07
06:36
07/07/22
06:36
THO

Thor Industries

$78.54 /

-1.57 (-1.96%)

Thor Industries announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THO Thor Industries
$78.54 /

-1.57 (-1.96%)

THO Thor Industries
$78.54 /

-1.57 (-1.96%)

06/09/22 Baird
Thor Industries price target lowered to $100 from $120 at Baird
05/19/22 DA Davidson
Thor Industries cut to Underperform at DA Davidson amid retail weakness
05/19/22 DA Davidson
Thor Industries downgraded to Underperform from Neutral at DA Davidson
05/16/22 BMO Capital
Thor Industries price target lowered to $95 from $110 at BMO Capital
THO Thor Industries
$78.54 /

-1.57 (-1.96%)

THO Thor Industries
$78.54 /

-1.57 (-1.96%)

Hot Stocks
Charah Solutions awarded multi-year contract for fly ash recycling in Indiana » 06:36
07/07/22
07/07
06:36
07/07/22
06:36
CHRA

Charah Solutions

$4.06 /

+0.15 (+3.84%)

Charah Solutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHRA Charah Solutions
$4.06 /

+0.15 (+3.84%)

CHRA Charah Solutions
$4.06 /

+0.15 (+3.84%)

05/12/22 B. Riley
Charah Solutions price target lowered to $5 from $7 at B. Riley
04/04/22 B. Riley
Charah Solutions outlook improving on regulatory catalysts, says B. Riley
01/04/22 Stifel
EPA rules could increase Charah's total addressable market, says Stifel
12/14/21 B. Riley
B. Riley starts 'ESG play' Charah with Buy, $7.50 target
Earnings
Immucell reports preliminary Q2 revenue $3.9M vs. $4.5M last year » 06:35
07/07/22
07/07
06:35
07/07/22
06:35
ICCC

Immucell

$8.28 /

-0.22 (-2.59%)

"A material…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICCC Immucell
$8.28 /

-0.22 (-2.59%)

ICCC Immucell
$8.28 /

-0.22 (-2.59%)

Upgrade
Allegiance Bancshares upgraded to Outperform from Market Perform at Raymond James » 06:34
07/07/22
07/07
06:34
07/07/22
06:34
ABTX

Allegiance Bancshares

$38.93 /

-0.28 (-0.71%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABTX Allegiance Bancshares
$38.93 /

-0.28 (-0.71%)

ABTX Allegiance Bancshares
$38.93 /

-0.28 (-0.71%)

Initiation
Toyo Gosei initiated with a Sell at Citi » 06:34
07/07/22
07/07
06:34
07/07/22
06:34
TYGIF

Toyo Gosei

/

+

Citi analyst Yuta…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James » 06:34
07/07/22
07/07
06:34
07/07/22
06:34
BSRR

Sierra Bancorp

$21.48 /

-0.18 (-0.83%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BSRR Sierra Bancorp
$21.48 /

-0.18 (-0.83%)

01/25/22 Janney Montgomery Scott
Sierra Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott
12/21/21 Keefe Bruyette
Keefe Bruyette assumes four California small- and mid-cap banks
12/20/21 Keefe Bruyette
Sierra Bancorp assumed with an Outperform at Keefe Bruyette
BSRR Sierra Bancorp
$21.48 /

-0.18 (-0.83%)

Hot Stocks
Henry Schein completes acquisition of Condor Dental » 06:34
07/07/22
07/07
06:34
07/07/22
06:34
HSIC

Henry Schein

$76.33 /

+0.165 (+0.22%)

Henry Schein has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HSIC Henry Schein
$76.33 /

+0.165 (+0.22%)

HSIC Henry Schein
$76.33 /

+0.165 (+0.22%)

07/05/22 Piper Sandler
Bottom in med tech shares is 'getting close,' says Piper Sandler
06/17/22 Stifel
Henry Schein price target lowered to $80 from $90 at Stifel
06/14/22 Baird
Baird downgrades Henry Schein to Neutral after dental survey points to slowing
06/14/22 Baird
Henry Schein downgraded to Neutral from Outperform at Baird
HSIC Henry Schein
$76.33 /

+0.165 (+0.22%)

HSIC Henry Schein
$76.33 /

+0.165 (+0.22%)

HSIC Henry Schein
$76.33 /

+0.165 (+0.22%)

Earnings
Park Aerospace reports Q1 EPS 9c vs. 13c last year » 06:34
07/07/22
07/07
06:34
07/07/22
06:34
PKE

Park Aerospace

$12.67 /

+0.15 (+1.20%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PKE Park Aerospace
$12.67 /

+0.15 (+1.20%)

Hot Stocks
Biolase promotes Jennifer Bright to CFO, Steven Sandor to COO » 06:34
07/07/22
07/07
06:34
07/07/22
06:34
BIOL

Biolase

$4.49 /

-0.19 (-4.06%)

Biolase announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIOL Biolase
$4.49 /

-0.19 (-4.06%)

BIOL Biolase
$4.49 /

-0.19 (-4.06%)

05/20/22 Lake Street
Biolase initiated with a Buy at Lake Street
08/19/21 Ascendiant
Biolase price target raised to $3 from $2 at Ascendiant
BIOL Biolase
$4.49 /

-0.19 (-4.06%)

Initiation
Digital Core REIT initiated with a Buy at Citi » 06:33
07/07/22
07/07
06:33
07/07/22
06:33
DGTCF

Digital Core REIT

/

+

Citi analyst Brandon Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
BitNile' subsidiary Ault Alliance did not acquire EYP » 06:32
07/07/22
07/07
06:32
07/07/22
06:32
NILE

BitNile

/

+

BitNile's subsidiary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NILE BitNile
/

+

NILE BitNile
/

+

03/15/22 Spartan Capital
BitNile initiated with a Buy at Spartan Capital
12/15/21 Ascendiant
BitNile initiated with a Buy at Ascendiant
NILE BitNile
/

+

NILE BitNile
/

+

NILE BitNile
/

+

Recommendations
Mirati Therapeutics price target lowered to $127 from $208 at Citi » 06:31
07/07/22
07/07
06:31
07/07/22
06:31
MRTX

Mirati Therapeutics

$69.87 /

-2.08 (-2.89%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$69.87 /

-2.08 (-2.89%)

MRTX Mirati Therapeutics
$69.87 /

-2.08 (-2.89%)

06/07/22 Stifel
Mirati Therapeutics price target raised to $111 from $105 at Stifel
06/07/22 JMP Securities
Mirati Therapeutics upgraded to Outperform from Market Perform at JMP Securities
05/27/22 Stifel
Mirati Therapeutics after-hours move lower 'overdone,' says Stifel
05/20/22 Guggenheim
Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
MRTX Mirati Therapeutics
$69.87 /

-2.08 (-2.89%)

  • 11
    Nov
MRTX Mirati Therapeutics
$69.87 /

-2.08 (-2.89%)

Downgrade
FS Bancorp downgraded to Market Perform from Outperform at Raymond James » 06:29
07/07/22
07/07
06:29
07/07/22
06:29
FSBW

FS Bancorp

$28.95 /

-0.09 (-0.31%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSBW FS Bancorp
$28.95 /

-0.09 (-0.31%)

FSBW FS Bancorp
$28.95 /

-0.09 (-0.31%)

Initiation
CTI BioPharma initiated with an Outperform at Cowen » 06:29
07/07/22
07/07
06:29
07/07/22
06:29
CTIC

CTI BioPharma

$6.01 /

-0.235 (-3.76%)

Cowen analyst Boris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

04/14/22 Stifel
Stifel reiterates Buy on CTI BioPharma following new treatment guidelines
03/01/22 Brookline
CTI BioPharma price target raised to $12 from $7.20 at Brookline
12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

CTIC CTI BioPharma
$6.01 /

-0.235 (-3.76%)

Downgrade
CytomX Therapeutics downgraded to Neutral from Outperform at Wedbush » 06:28
07/07/22
07/07
06:28
07/07/22
06:28
CTMX

CytomX Therapeutics

$1.96 /

+0.015 (+0.77%)

Wedbush analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

06:14 Today Barclays
CytomX Therapeutics price target lowered to $3.50 from $7 at Barclays
04:44 Today Mizuho
CytomX Therapeutics downgraded to Neutral from Buy at Mizuho
04:42 Today Piper Sandler
CytomX Therapeutics downgraded to Neutral from Overweight at Piper Sandler
06/23/22 BMO Capital
CytomX Therapeutics initiated with an Outperform at BMO Capital
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

Recommendations
Iveric bio price target raised to $30 from $25 at Morgan Stanley » 06:28
07/07/22
07/07
06:28
07/07/22
06:28
ISEE

Iveric bio

$10.44 /

+0.3 (+2.96%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISEE Iveric bio
$10.44 /

+0.3 (+2.96%)

ISEE Iveric bio
$10.44 /

+0.3 (+2.96%)

06/08/22 Guggenheim
Iveric bio initiated with a Buy at Guggenheim
06/08/22 BofA
Iveric bio initiated with a Buy at BofA
05/12/22 B. Riley
B. Riley puts Neutral rating on Iveric bio in 'contrarian call'
05/12/22 B. Riley
Iveric bio initiated with a Neutral at B. Riley
ISEE Iveric bio
$10.44 /

+0.3 (+2.96%)

  • 22
    Oct
  • 13
    Jul
ISEE Iveric bio
$10.44 /

+0.3 (+2.96%)

Recommendations
Warner Music price target lowered to $27 from $31 at Citi » 06:28
07/07/22
07/07
06:28
07/07/22
06:28
WMG

Warner Music

$25.03 /

-0.6 (-2.34%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WMG Warner Music
$25.03 /

-0.6 (-2.34%)

WMG Warner Music
$25.03 /

-0.6 (-2.34%)

07/05/22 Barclays
Warner Music price target lowered to $33 from $37 at Barclays
06/03/22 Guggenheim
Warner Music price target raised to $34 from $30 at Guggenheim
05/17/22 Citi
Warner Music price target lowered to $31 from $41 at Citi
05/11/22 Barclays
Warner Music price target lowered to $37 from $49 at Barclays
WMG Warner Music
$25.03 /

-0.6 (-2.34%)

  • 04
    Jan
  • 09
    Dec
  • 22
    Sep
  • 09
    Sep
WMG Warner Music
$25.03 /

-0.6 (-2.34%)

Recommendations
Warner Bros. Discovery price target lowered to $29 from $40 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
WBD

Warner Bros. Discovery

$14.26 /

-0.195 (-1.35%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

06/29/22 Benchmark
Benchmark starts Warner Bros. Discovery at Buy, expects shares to recover
06/29/22 Benchmark
Warner Bros. Discovery initiated with a Buy at Benchmark
06/16/22 JPMorgan
Warner Bros. Discovery reinstated with a Neutral at JPMorgan
06/02/22 Wolfe Research
Warner Bros. Discovery price target lowered to $20 from $30 at Wolfe Research
WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

WBD Warner Bros. Discovery
$14.26 /

-0.195 (-1.35%)

Recommendations
Disney price target lowered to $145 from $165 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
DIS

Disney

$96.07 /

-1.15 (-1.18%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$96.07 /

-1.15 (-1.18%)

DIS Disney
$96.07 /

-1.15 (-1.18%)

07/05/22 Vertical Group
Disney downgraded to Mixed from Positive at Vertical Group
06/30/22 Morgan Stanley
Disney price target lowered to $125 from $170 at Morgan Stanley
06/15/22 Evercore ISI
Disney showing good financial discipline with IPL renewal, says Evercore ISI
06/06/22 Deutsche Bank
Disney price target lowered to $130 from $191 at Deutsche Bank
DIS Disney
$96.07 /

-1.15 (-1.18%)

DIS Disney
$96.07 /

-1.15 (-1.18%)

DIS Disney
$96.07 /

-1.15 (-1.18%)

DIS Disney
$96.07 /

-1.15 (-1.18%)

Recommendations
Vivid Seats price target lowered to $12 from $14 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
SEAT

Vivid Seats

$7.55 /

-0.43 (-5.39%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SEAT Vivid Seats
$7.55 /

-0.43 (-5.39%)

SEAT Vivid Seats
$7.55 /

-0.43 (-5.39%)

05/10/22 Raymond James
Vivid Seats price target lowered to $11 from $17 at Raymond James
03/11/22 Benchmark
Vivid Seats price target lowered to $17 from $19 at Benchmark
01/31/22 Credit Suisse
Vivid Seats initiated with an Outperform at Credit Suisse
01/03/22 Citi
Citi upgrades Vivid Seats to Buy on 'unwarranted' selloff
SEAT Vivid Seats
$7.55 /

-0.43 (-5.39%)

Recommendations
Unity Software price target lowered to $68 from $71 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
U

Unity Software

/

+

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
U Unity Software
/

+

U Unity Software
/

+

06/30/22 KeyBanc
Unity Software initiated with a Sector Weight at KeyBanc
06/29/22 BTIG
Unity Software price target lowered to $72 from $110 at BTIG
06/21/22 Credit Suisse
Unity Software price target lowered to $105 from $137 at Credit Suisse
06/16/22 Jefferies
Unity Software price target lowered to $36 from $40 at Jefferies
U Unity Software
/

+

U Unity Software
/

+

U Unity Software
/

+

U Unity Software
/

+

Recommendations
Spotify price target lowered to $150 from $165 at Citi » 06:27
07/07/22
07/07
06:27
07/07/22
06:27
SPOT

Spotify

/

+

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPOT Spotify
/

+

SPOT Spotify
/

+

06/29/22 JPMorgan
Spotify price target lowered to $145 from $150 at JPMorgan
06/15/22 Wells Fargo
Wells Fargo upgrades Spotify to Equal Weight, raises price target to $124
06/15/22 Wells Fargo
Spotify upgraded to Equal Weight from Underweight at Wells Fargo
06/09/22 Goldman Sachs
Spotify price target lowered to $133 from $150 at Goldman Sachs
SPOT Spotify
/

+

SPOT Spotify
/

+

SPOT Spotify
/

+

SPOT Spotify
/

+

Downgrade
Veritex downgraded to Outperform from Strong Buy at Raymond James » 06:26
07/07/22
07/07
06:26
07/07/22
06:26
VBTX

Veritex

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VBTX Veritex
/

+

VBTX Veritex
/

+

06/13/22 DA Davidson
DA Davidson says recent and pending investments by Veritex support tailwinds
01/27/22 Raymond James
Veritex price target raised to $49 from $46 at Raymond James
10/28/21 Piper Sandler
Veritex price target raised to $46 from $42 at Piper Sandler
09/22/21 DA Davidson
Veritex price target raised to $44 from $40 at DA Davidson
  • 04
    Mar
Recommendations
Sportradar price target lowered to $18 from $23 at Citi » 06:26
07/07/22
07/07
06:26
07/07/22
06:26
SRAD

Sportradar

$7.93 /

-0.39 (-4.69%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRAD Sportradar
$7.93 /

-0.39 (-4.69%)

SRAD Sportradar
$7.93 /

-0.39 (-4.69%)

05/19/22 Benchmark
Sportradar price target lowered to $15 from $30 at Benchmark
05/19/22 Craig-Hallum
Sportradar price target lowered to $25 from $30 at Craig-Hallum
05/19/22 JPMorgan
Sportradar price target lowered to $14 from $24 at JPMorgan
05/19/22 Deutsche Bank
Sportradar price target lowered to $13 from $20 at Deutsche Bank
SRAD Sportradar
$7.93 /

-0.39 (-4.69%)

  • 14
    Sep
SRAD Sportradar
$7.93 /

-0.39 (-4.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.